Stockscreener 앱 받기
11.70
2.65%
0.36
전일 마감가:
$11.34
열려 있는:
$11.48
하루 거래량:
36,745
Relative Volume:
0.03
시가총액:
$1.02B
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-3.5329
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
+3.57%
1개월 성능:
+21.98%
6개월 성능:
+85.30%
1년 성능:
-14.20%
1일 변동 폭
$11.48
$11.76
1주일 범위
$10.00
$11.86
52주 변동 폭
$5.1501
$15.12
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
11.76 | 987.09M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.89 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.66 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.08 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
773.51 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.16 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 개시 | Goldman | Buy |
| 2025-09-05 | 개시 | Craig Hallum | Buy |
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Immunome Inc. stock chart pattern explained2025 Retail Activity & Community Verified Swing Trade Signals - newser.com
Using fundamentals and technicals on Immunome Inc.Market Risk Analysis & Scalable Portfolio Growth Methods - newser.com
How institutional ownership impacts Immunome Inc. stock2025 Market Trends & Weekly Market Pulse Updates - newser.com
How Immunome Inc. stock reacts to global recession fearsCPI Data & Daily Oversold Bounce Ideas - newser.com
Does Immunome Inc. fit your quant trading model2025 Analyst Calls & Detailed Earnings Play Strategies - newser.com
Immunome, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Market reaction to Immunome Inc.’s recent newsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Can trapped investors hope for a rebound in Immunome Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Key resistance and support levels for Immunome Inc.July 2025 PostEarnings & Technical Pattern Alert System - newser.com
Signal strength of Immunome Inc. stock in tech scannersTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Immunome, Inc. Hits Day Low of $10.02 Amid Price Pressure - Markets Mojo
Immunome, Inc. Hits Day High with 14.13% Surge in Stock Price - Markets Mojo
Immunome, Inc. Hits Day High with Strong 8.09% Intraday Surge - Markets Mojo
How high can Immunome Inc. stock goQuarterly Trade Report & Community Consensus Trade Alerts - newser.com
Trend analysis for Immunome Inc. this weekWeekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Is Immunome Inc. stock attractive for income investors2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Goldman Sachs Sees Positive Outlook for Immunome with $26 Price Target - timothysykes.com
Will Immunome's (IMNM) Antibody Partnership Mark a Shift in Its R&D Strategy? - simplywall.st
Immunome Secures Strategic Partnerships, Boosts Market Potential - StocksToTrade
Immunome Stock On the Rise Amid Strategic Collaborations - timothysykes.com
Will Immunome's (IMNM) Antibody Collaboration Refocus Its Pipeline Expansion Strategy? - Yahoo Finance
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Immunome (NASDAQ:IMNM) Stock Price Down 5.9%Here's Why - MarketBeat
Immunome (IMNM) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Stocks With Rising Relative Strength: Immunome - Investor's Business Daily
Using R and stats models for Immunome Inc. forecastingForecast Cut & Long-Term Growth Plans - newser.com
Goldman Sachs Group Inc. Decreases Stake in Immunome, Inc. $IMNM - MarketBeat
Immunome (NASDAQ:IMNM) Shares Up 8%What's Next? - MarketBeat
Immunome stock a ‘buy’ on ‘rich pipeline’ of oncology therapeutics: analysts - Proactive financial news
Goldman Sachs Initiates Immunome(IMNM.US) With Buy Rating - 富途牛牛
Ranking Immunome Inc. among high performing stocks via toolsMarket Growth Review & AI Driven Price Forecasts - newser.com
The Goldman Sachs Group Initiates Coverage on Immunome (NASDAQ:IMNM) - MarketBeat
Goldman Sachs initiates coverage on Immunome stock with Buy rating - Investing.com India
Goldman Sachs initiates coverage on Immunome stock with Buy rating By Investing.com - Investing.com South Africa
Is Immunome Inc. still worth holding after the dip2025 Risk Factors & Fast Gain Stock Tips - newser.com
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.35%
0.96%
자본화:
|
볼륨(24시간):